Why Inteliquent (IQNT) Is Popping on Thursday

NEW YORK (TheStreet) -- Inteliquent (IQNT) is booking gains on Thursday on better-than-expected quarterly earnings and sales and guidance above consensus.

By midafternoon, shares had added 14.9% to $13.72. Trading volume of 1.66 million was more than three times its three-month daily average.

The voice and data host recorded net income of 27 cents a share in the three months to December. Analysts surveyed by Thomson Reuters had predicted 18 cents a share.

Revenue of $50.24 million was $130,000 higher than analyst consensus.

For fiscal 2014, management guided revenue between $200 million and $210 million. Analysts had forecast $199.55 million in total sales.

Must Read: Tesla's Partying Like It's 1999

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings team rates INTELIQUENT INC as a Hold with a ratings score of C-. The team has this to say about their recommendation:

"We rate INTELIQUENT INC (IQNT) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we find that the company's return on equity has been disappointing."

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

More from Markets

Stocks Tumble as Dow Heads for Eighth Straight Drop

Stocks Tumble as Dow Heads for Eighth Straight Drop

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Video: Here's Why One Markets Pro Is Raising Cash Right Now

Mesoblast Soars on Stem-Cell Treatment Data

Mesoblast Soars on Stem-Cell Treatment Data

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone

Bank of England Holds Rates Steady, But Vote Shift Signals Hawkish Tone